PPH vs. BBC
PPH (VanEck Vectors Pharmaceutical ETF) and BBC (Virtus LifeSci Biotech Clinical Trials ETF) are both Health & Biotech Equities funds - PPH tracks the MVIS US Listed Pharmaceutical 25 Index while BBC tracks the LifeSci Biotechnology Clinical Trials Index. Both are passively managed. Over the past 10 years, PPH returned 7.46%/yr vs 7.64%/yr for BBC. A 0.51 correlation means they provide meaningful diversification when combined. PPH charges 0.36%/yr vs 0.79%/yr for BBC.
Performance
PPH vs. BBC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PPH achieves a -0.76% return, which is significantly lower than BBC's 8.64% return. Both investments have delivered pretty close results over the past 10 years, with PPH having a 7.46% annualized return and BBC not far ahead at 7.64%.
PPH
- 1D
- 0.33%
- 1M
- -0.56%
- YTD
- -0.76%
- 6M
- 2.14%
- 1Y
- 17.87%
- 3Y*
- 12.03%
- 5Y*
- 9.22%
- 10Y*
- 7.46%
BBC
- 1D
- 0.43%
- 1M
- -6.52%
- YTD
- 8.64%
- 6M
- 14.08%
- 1Y
- 116.78%
- 3Y*
- 19.99%
- 5Y*
- -1.96%
- 10Y*
- 7.64%
PPH vs. BBC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PPH VanEck Vectors Pharmaceutical ETF | -0.76% | 22.00% | 8.05% | 6.95% | 2.64% | 17.79% | 5.49% | 19.39% | -5.89% | 15.23% |
BBC Virtus LifeSci Biotech Clinical Trials ETF | 8.64% | 63.77% | -1.11% | -1.80% | -35.13% | -22.31% | 30.32% | 63.81% | -18.29% | 57.85% |
Correlation
The correlation between PPH and BBC is 0.42, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.42 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.38 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.42 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.49 |
Correlation (All Time) Calculated using the full available price history since Dec 18, 2014 | 0.51 |
The correlation between PPH and BBC shifts across timeframes, from 0.38 (3 years) to 0.51 (all time), reflecting how their relationship changes across market environments.
PPH vs. BBC - Sectors Allocation Comparison
Sectors
PPH
BBC
Healthcare
Industrials
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
PPH
BBC
Industrials
PPH
BBC
-
Basic Materials
PPH
-
BBC
-
Communication Services
PPH
-
BBC
-
Consumer Cyclical
PPH
-
BBC
-
Consumer Defensive
PPH
-
BBC
-
Energy
PPH
-
BBC
-
Financial Services
PPH
-
BBC
-
Real Estate
PPH
-
BBC
-
Technology
PPH
-
BBC
-
Utilities
PPH
-
BBC
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PPH vs. BBC — Risk / Return Rank
PPH
BBC
PPH vs. BBC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Pharmaceutical ETF (PPH) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PPH | BBC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.28 | ||
| Sortino ratioReturn per unit of downside risk | -2.33 | ||
| Omega ratioGain probability vs. loss probability | 1.19 | 1.46 | -0.27 |
| Calmar ratioReturn relative to maximum drawdown | 1.67 | 7.78 | -6.11 |
| Martin ratioReturn relative to average drawdown | 3.88 | 24.80 | -20.91 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PPH | BBC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.04 | 3.32 | -2.28 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.61 | -0.05 | +0.67 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.44 | 0.20 | +0.24 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.30 | 0.12 | +0.18 |
Drawdowns
PPH vs. BBC - Drawdown Comparison
The maximum PPH drawdown since its inception was -51.45%, smaller than the maximum BBC drawdown of -76.85%. Use the drawdown chart below to compare losses from any high point for PPH and BBC.
Loading charts...
Drawdown Indicators
| PPH | BBC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -51.45% | -76.85% | +25.40% |
Max Drawdown (1Y)Largest decline over 1 year | -10.76% | -15.10% | +4.34% |
Max Drawdown (3Y)Largest decline over 3 years | -18.06% | -54.45% | +36.39% |
Max Drawdown (5Y)Largest decline over 5 years | -20.26% | -72.44% | +52.18% |
Max Drawdown (10Y)Largest decline over 10 years | -29.70% | -76.85% | +47.15% |
Current DrawdownCurrent decline from peak | -8.34% | -30.27% | +21.93% |
Average DrawdownAverage peak-to-trough decline | -17.31% | -37.14% | +19.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.61% | 4.73% | -0.12% |
Volatility
PPH vs. BBC - Volatility Comparison
The current volatility for VanEck Vectors Pharmaceutical ETF (PPH) is 4.73%, while Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a volatility of 10.93%. This indicates that PPH experiences smaller price fluctuations and is considered to be less risky than BBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PPH | BBC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.73% | 10.93% | -6.20% |
Volatility (6M)Calculated over the trailing 6-month period | 11.67% | 26.43% | -14.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.26% | 35.50% | -18.24% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.07% | 39.31% | -24.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.96% | 37.74% | -20.78% |
PPH vs. BBC - Expense Ratio Comparison
PPH has a 0.36% expense ratio, which is lower than BBC's 0.79% expense ratio.
Dividends
PPH vs. BBC - Dividend Comparison
PPH's dividend yield for the trailing twelve months is around 2.12%, more than BBC's 1.56% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.56% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
PPH VanEck Vectors Pharmaceutical ETF | 2.12% | 1.78% | 1.98% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% |
Frequently Asked Questions
PPH and BBC have a correlation of 0.42, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBC has higher volatility (10.93%) compared to PPH (4.73%). In terms of maximum drawdown, PPH dropped -51.45% vs BBC's -76.85%.
On 10-year performance, BBC leads with 7.64% vs 7.46% for PPH. On fees, PPH is cheaper at 0.36% per year. On volatility, PPH has been the lower-risk option at 4.73%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, BBC has performed better with a 7.64% return vs 7.46%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PPH is cheaper with a 0.36% expense ratio, compared with 0.79% for BBC.
PPH has the higher dividend yield at 2.12%, compared with 1.56% for BBC.
PPH tracks MVIS US Listed Pharmaceutical 25 Index, while BBC tracks LifeSci Biotechnology Clinical Trials Index. They also come from different issuers: VanEck and Virtus Investment Partners. Their fees differ too: 0.36% for PPH and 0.79% for BBC.
BBC currently has the higher Sharpe Ratio (3.32 vs 1.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PPH and BBC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer